Tomonori Yokoyama

Title: The Innovations of Tomonori Yokoyama

Introduction

Tomonori Yokoyama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for diseases associated with CCR3, such as asthma and allergic rhinitis. With a total of 3 patents to his name, Yokoyama's work is recognized for its potential impact on medical science.

Latest Patents

Yokoyama's latest patents include a cyclic amine CCR3 antagonist, which is a medicine containing a cyclic amine derivative. This medicine serves as an active ingredient for treating or preventing diseases in which CCR3 participates. His second patent involves 4,4-disubstituted piperidine derivatives that exhibit CCR3 antagonism. These low molecular compounds inhibit the binding of CCR3 ligands to CCR3 on target cells, providing a promising avenue for treating conditions like asthma and allergic rhinitis.

Career Highlights

Tomonori Yokoyama is currently associated with Teijin Limited, a company known for its innovative approaches in various sectors, including healthcare. His work at Teijin has allowed him to focus on developing effective pharmaceutical solutions that address pressing health issues.

Collaborations

Yokoyama has collaborated with notable colleagues such as Akinobu Nakanishi and Yoshiyuki Sawai. These partnerships have fostered a collaborative environment that enhances the research and development of new medical treatments.

Conclusion

Tomonori Yokoyama's contributions to pharmaceutical innovation highlight his dedication to improving health outcomes through scientific research. His patents reflect a commitment to addressing significant medical challenges, making him a valuable figure in the field of invention.